Effectiveness of antiepileptic GABA analogues for the treatment of neuropathic pain

Pharmacologyonline

Volumn 1, Issue , 2010, Pages 575-590

  Yogeeswari, P ^a   Ragavendran, J V ^b   Sriram, D ^a   Priyanka, A ^a   Ganguly, S ^a   Sunil Kumar Reddy, A ^a   Semwal, Arvind ^a  

^a BIRLA INSTITUTE OF TECHNOLOGY AND SCIENCE   (India)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

aminobutyric acid; Allodynia; Hyperalgesia; Writhing

Indexed keywords

4 (1,3 DIOXO 1,3 DIHYDRO 2H ISOINDOL 2 YL) N' [(1 PHENYL)METHYLENE]BUTANOYL HYDRAZIDE; 4 (1,3 DIOXO 1,3 DIHYDRO 2H ISOINDOL 2 YL) N' [(1,3 HYDROXYPHENYL)METHYLENE]BUTANOYL HYDRAZIDE; 4 (1,3 DIOXO 1,3 DIHYDRO 2H ISOINDOL 2 YL) N' [(2 HYDROXYPHENYL)ETHYLIDENE]BUTANOYL HYDRAZIDE; 4 (1,3 DIOXO 1,3 DIHYDRO 2H ISOINDOL 2 YL) N' [(3 NITROPHENYL)METHYLENE]BUTANOYL HYDRAZIDE; 4 (1,3 DIOXO 1,3 DIHYDRO 2H ISOINDOL 2 YL) N' [(4 HYDROXY 3 METHOXYPHENYL)METHYLENE]BUTANOYL HYDRAZIDE; 4 (1,3 DIOXO 1,3 DIHYDRO 2H ISOINDOL 2 YL) N' [(4 NITROPHENYL)ETHYLIDENE]BUTANOYL HYDRAZIDE; 4 (1,3 DIOXO 1,3 DIHYDRO 2H ISOINDOL 2 YL) N' [(4 NITROPHENYL)METHYLENE]BUTANOYL HYDRAZIDE; 4 (1,3 DIOXO 1,3 DIHYDRO 2H ISOINDOL 2 YL) N' [1 (3 AMINOPHENYL)ETHYLIDENE]BUTANOYL HYDRAZIDE; 4 (1,3 DIOXO 1,3 DIHYDRO 2H ISOINDOL 2 YL) N' [1 (4 HYDROXYPHENYL)ETHYLIDENE]BUTANOYL HYDRAZIDE; 4 (1,3 DIOXO 1,3 DIHYDRO 2H ISOINDOL 2 YL) N' [1 (4 METHYLPHENYL)ETHYLIDENE]BUTANOYL HYDRAZIDE; 4 (1,3 DIOXO 1,3 DIHYDRO 2H ISOINDOL 2 YL) N' [1 (4 METHYLPROPYLIDENE)]BUTANOYL HYDRAZIDE; 4 (1,3 DIOXO 1,3 DIHYDRO 2H ISOINDOL 2 YL) N' [1 PHENYLBENZYLIDENE]BUTANOYL HYDRAZIDE; 4 (1,3 DIOXO 1,3 DIHYDRO 2H ISOINDOL 2 YL) N' [1 PHENYLETHYLIDENE]BUTANOYL HYDRAZIDE; 4 (1,3 DIOXO 1,3 DIHYDRO 2H ISOINDOL 2 YL) N' [2 OXO 1,2 DIHYDRO 3H INDOL 3 YLIDENE]BUTANOYL HYDRAZIDE; 4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID A RECEPTOR STIMULATING AGENT; ACETIC ACID; ACETYLSALICYLIC ACID; CARBAMAZEPINE; GABAPENTIN; LAMOTRIGINE; N' CYCLOHEXYLIDENE 4 (1,3 DIOXO 1,3 DIHYDRO 2H ISOINDOL 2 YL)BUTANOYL HYDRAZIDE; N' CYCLOPENTYLIDENE 4 (1,3 DIOXO 1,3 DIHYDRO 2H ISOINDOL 2 YL)BUTANOYL HYDRAZIDE; UNCLASSIFIED DRUG; VOLTAGE GATED SODIUM CHANNEL;

ALLODYNIA; ANALGESIA; ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHANNEL GATING; CLINICAL OBSERVATION; CONTROLLED STUDY; DISEASE MODEL; DRUG EFFICACY; DRUG STRUCTURE; FEMALE; GABAERGIC TRANSMISSION; HYPERALGESIA; MALE; MOUSE; NERVE LIGATION; NEUROPATHIC PAIN; NEUROTRANSMISSION; NOCICEPTION; NONHUMAN; SPINAL NERVE; WRITHING TEST;

EID: 77953208857     PISSN: None     EISSN: 18278620     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. McQuay HJ, Tramer M, Nye BA, et al. A systematic review of antidepressants in neuropathic pain. Pain 1996; 68:217-227.
2. Sindrup SH, Jensen TS. Efficacy of pharmacological treatments of neuropathic pain: an update and effect related to mechanism of drug action. Pain 1999; 83:389-400.
3. Laughlin TM, Tram KV, Wilcox GL, et al. Comparison of antiepileptic drugs tiagabine, lamotrigine, and gabapentin in mouse models of acute, prolonged, and chronic nociception. J Pharmacol Exp Ther 2002; 302:1168-1175.
4. Sivilotti L, Nistri A. GABA receptor mechanisms in the central nervous system. Prog Neurobiol 1991; 36:35-92.
5. Meldrum BS. Epilepsy and gamma-aminobutyric acid mediated inhibition. Int Rev Neurobiol 1975; 17:1-36.
6. Loscher W. In: Bartholini G, Bossi L, Lloyd KG, Morselli PL, eds. Epilepsy and GABA Receptor Agonists: Basic and Therapeutic Research. (L.E.R.S. monograph series). Raven Press, New York, 1985: 109-119.
7. Curtis DR. In: Krogsgaard-Larsen P, Scheel-Kruger J, Kofoed H, eds. GABA-Neurotransmitters: Pharmacochemical Biochemicaland Pharmacological Aspects. Munksgaard, Copenhagen, 1978, pp. 17-27.
8. Ibuki T, Hama AT, Wang XT, et al. Loss of GABA immunoreactivity in the spinal dorsal horn of rats with peripheral nerve injury and promotion of recovery by adrenal medullary grafts. Neuroscience 1997; 76:845-858.
9. Franek M, Vaculin S, Rokyta R. GABAB receptor agonist baclofen has non-specific antinociceptive effect in the model of peripheral neuropathy in the rat. Physiol Res 2004; 53:351-355.
10. Hunter JC, Gogas KR, Hedley LR, et al. The effect of novel anti-epileptic drugs in rat experimental models of acute and chronic pain. Eur J Pharmacol 1997; 324:153-160.
11. Ragavendran JV, Sriram D, Patel SK, et al. Design and Synthesis of anticonvulsants from a combined pthalimide-GABA-anilide and hydrazone pharmacophore. Eur J Med Chem 2007; 42:146-151.
12. Yogeeswari P, Raghavendran JV, Sriram D, et al. Discovery of 4-aminobutyric acid derivatives possessing anticonvulsant and antinociceptive activities: A hybrid pharmacophore approach. J Med Chem 2007; 50:2459-2467.
13. Yogeeswari P, Sriram D, Sahitya P, et al. Synthesis and anticonvulsant activityof4-(2-(2,6-dimethylphenylamino)-2-oxoethylamino)-N-(substituted)butanamides: A pharmacophoric hybrid approach. Bioorg Med Chem Lett 2007; 17:3712-3715.
14. Yogeeswari P, Ragavendran JV, Sriram D, et al. Newer N-pthaloyl GABA derivatives with antiallodynic and antihyperalgesic activities in both sciatic nerve and spinal nerve ligation models of neuropathic pain. Pharmacol 2007; 81:21-31.
15. Ragavendran JV, Sriram D, Kotapati S, et al. Newer GABA derivatives for the treatment of epilepsy including febrile seizures: A bioisosteric approach. Eur J Med Chem 2008; 43:2650-5.
16. Siegmund EA, Cadmus RA. A method for evaluating both nonnarcotic and narcotic analgesics. Proc Soc Exp Biol 1957; 95:729-731.
17. Bennett GJ, Xie YK, A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain 1988; 33:87-107.
18. Kim S, Chung JM, An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat. Pain 1992; 50:355-363.
19. Choi Y, Yoon YW, Na HS, et al. Behavioral signs of ongoing pain and cold allodynia in a rat model of neuropathic pain. Pain 1994; 59:369-376.
20. Field MJ, Bramwell S, Hughes J, et al. Detection of static and dynamic components of mechanical allodynia in rat models of neuropathic pain: Are they signalled by distinct primary sensory neurones?. Pain 1999; 83:303-311.
21. Field MJ, McCleary S, Hughes J, et al. Gabapentin and pregabalin, but not morphine and amitriptyline, block both static and dynamic components of mechanical allodynia induced by streptozocin in the rat. Pain 1999; 80:391-398.
22. Caudle RM, Mannes AJ, Benoliel R, et al. Intrathecally administered cholera toxin blocks allodynia and hyperalgesia in persistent pain models. J Pain 2001; 2:118-127.
23. Gonzalez MI, Field MJ, Hughes J, et al. Evaluation of selective NK1 receptor antagonist CI-1021 in animal models of inflammatory and neuropathic pain. J Pharmacol Exp Ther 2000; 294:444-450.
24. Chakraborty A, Devi RKB, Rita S, et al. Preliminary studies on anti-inflammatory and analgesic activities of Spilanthes acmella in experimental animal models. Indian J Pharmacol 2004; 36:148-150.